Sattar N - Search Results

1

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.

Smolen JS, Schoels MM, Nishimoto N, Breedveld FC, Burmester GR, Dougados M, Emery P, Ferraccioli G, Gabay C, Gibofsky A, Gomez-Reino JJ, Jones G, Kvien TK, Murakami M, Betteridge N, Bingham CO 3rd, Bykerk V, Choy EH, Combe B, Cutolo M, Graninger W, Lanas A, Martin-Mola E, Montecucco C, Ostergaard M, Pavelka K, Rubbert-Roth A, Sattar N, Scholte-Voshaar M, Tanaka Y, Trauner M, Valentini G, Winthrop KL, de Wit M, van der Heijde D. Smolen JS, et al. Among authors: sattar n. Ann Rheum Dis. 2013 Apr;72(4):482-92. doi: 10.1136/annrheumdis-2012-202469. Epub 2012 Nov 21. Ann Rheum Dis. 2013. PMID: 23172750 Free PMC article.

2

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.

Peters MJ, Watt P, Cherry L, Welsh P, Henninger E, Dijkmans BA, McInnes IB, Nurmohamed MT, Sattar N. Peters MJ, et al. Among authors: sattar n. Ann Rheum Dis. 2010 Sep;69(9):1687-90. doi: 10.1136/ard.2009.114207. Epub 2009 Jul 28. Ann Rheum Dis. 2010. PMID: 19640853 Clinical Trial.

3

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP, Symmons DP, Nightingale P, Metsios GS, Kitas GD. Toms TE, et al. Among authors: sattar n. Ann Rheum Dis. 2010 Apr;69(4):683-8. doi: 10.1136/ard.2009.115717. Epub 2009 Oct 23. Ann Rheum Dis. 2010. PMID: 19854705

4

Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.

Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N, Nurmohamed MT. Peters MJ, et al. Among authors: sattar n. Ann Rheum Dis. 2010 Jul;69(7):1281-5. doi: 10.1136/ard.2009.119412. Epub 2009 Nov 23. Ann Rheum Dis. 2010. PMID: 19934107 Clinical Trial.

5

The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.

van Sijl AM, Peters MJ, Knol DL, de Vet RH, Sattar N, Dijkmans BA, Smulders YM, Nurmohamed MT. van Sijl AM, et al. Among authors: sattar n. Semin Arthritis Rheum. 2011 Dec;41(3):393-400. doi: 10.1016/j.semarthrit.2011.04.003. Epub 2011 Jun 12. Semin Arthritis Rheum. 2011. PMID: 21665247

6

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.

Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Jamnitski A, et al. Among authors: sattar n. Ann Rheum Dis. 2013 Feb;72(2):211-6. doi: 10.1136/annrheumdis-2011-201194. Epub 2012 Apr 24. Ann Rheum Dis. 2013. PMID: 22532629 Review.

7

How low to aim in rheumatoid arthritis? Learning from other disciplines.

Porter D, Dale J, Sattar N. Porter D, et al. Among authors: sattar n. Ann Rheum Dis. 2014 Mar;73(3):480-2. doi: 10.1136/annrheumdis-2013-204339. Epub 2013 Nov 18. Ann Rheum Dis. 2014. PMID: 24249809 Review.

8

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.

McInnes IB, Thompson L, Giles JT, Bathon JM, Salmon JE, Beaulieu AD, Codding CE, Carlson TH, Delles C, Lee JS, Sattar N. McInnes IB, et al. Among authors: sattar n. Ann Rheum Dis. 2015 Apr;74(4):694-702. doi: 10.1136/annrheumdis-2013-204345. Epub 2013 Dec 24. Ann Rheum Dis. 2015. PMID: 24368514 Free PMC article. Clinical Trial.

9

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.

Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, Sattar N. Gabay C, et al. Among authors: sattar n. Ann Rheum Dis. 2016 Oct;75(10):1806-12. doi: 10.1136/annrheumdis-2015-207872. Epub 2015 Nov 27. Ann Rheum Dis. 2016. PMID: 26613768 Free PMC article. Clinical Trial.

10

Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.

Robertson J, Porter D, Sattar N, Packard CJ, Caslake M, McInnes I, McCarey D. Robertson J, et al. Among authors: sattar n. Ann Rheum Dis. 2017 Nov;76(11):1949-1952. doi: 10.1136/annrheumdis-2017-211708. Epub 2017 Sep 15. Ann Rheum Dis. 2017. PMID: 28916714 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,587 results

Search Page

Filters